U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231315) titled 'INTERACT4 Expansion - Validation Study' on Sept. 17.
Brief Summary: As an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the diagnostic accuracy of GFAP measured using a point-of-care device, for identifying ICH in participants presenting with acute stroke-like symptoms in the pre-hospital setting compared with imaging-confirmed ICH.
Study Start Date: Feb. 01, 2026
Study Type: OBSERVATIONAL
Condition:
Intracerebral Hemorrhage
Intervention:
DIAGNOSTIC_TEST: LVOne
LVOne is an in vitro diagnostic rapid lateral flow chromatographic i...